470 related articles for article (PubMed ID: 16736939)
1. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment.
Cohen SM; Arnold LL; Eldan M; Lewis AS; Beck BD
Crit Rev Toxicol; 2006 Feb; 36(2):99-133. PubMed ID: 16736939
[TBL] [Abstract][Full Text] [Related]
2. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
[TBL] [Abstract][Full Text] [Related]
3. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
[TBL] [Abstract][Full Text] [Related]
5. Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.
Naranmandura H; Carew MW; Xu S; Lee J; Leslie EM; Weinfeld M; Le XC
Chem Res Toxicol; 2011 Sep; 24(9):1586-96. PubMed ID: 21815631
[TBL] [Abstract][Full Text] [Related]
6. Arsenic-induced bladder cancer in an animal model.
Cohen SM; Ohnishi T; Arnold LL; Le XC
Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
[TBL] [Abstract][Full Text] [Related]
7. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder.
Kinoshita A; Wanibuchi H; Wei M; Yunoki T; Fukushima S
Toxicol Appl Pharmacol; 2007 Jun; 221(3):295-305. PubMed ID: 17481689
[TBL] [Abstract][Full Text] [Related]
8. Distributions and chemical forms of arsenic after intravenous administration of dimethylarsinic and monomethylarsonic acids to rats.
Suzuki KT; Katagiri A; Sakuma Y; Ogra Y; Ohmichi M
Toxicol Appl Pharmacol; 2004 Aug; 198(3):336-44. PubMed ID: 15276413
[TBL] [Abstract][Full Text] [Related]
9. Methylation of inorganic arsenic in different mammalian species and population groups.
Vahter M
Sci Prog; 1999; 82 ( Pt 1)(1):69-88. PubMed ID: 10445007
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent effects on the disposition of monomethylarsonic acid and dimethylarsinic acid in the mouse after intravenous administration.
Hughes MF; Kenyon EM
J Toxicol Environ Health A; 1998 Jan; 53(2):95-112. PubMed ID: 9444314
[TBL] [Abstract][Full Text] [Related]
12. Role of the alkali labile sites, reactive oxygen species and antioxidants in DNA damage induced by methylated trivalent metabolites of inorganic arsenic.
Soto-Reyes E; Del Razo LM; Valverde M; Rojas E
Biometals; 2005 Oct; 18(5):493-506. PubMed ID: 16333750
[TBL] [Abstract][Full Text] [Related]
13. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
[TBL] [Abstract][Full Text] [Related]
14. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.
Aposhian HV; Zakharyan RA; Avram MD; Sampayo-Reyes A; Wollenberg ML
Toxicol Appl Pharmacol; 2004 Aug; 198(3):327-35. PubMed ID: 15276412
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of arsenic and its toxicological relevance.
Watanabe T; Hirano S
Arch Toxicol; 2013 Jun; 87(6):969-79. PubMed ID: 22811022
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro.
Nascimento MG; Suzuki S; Wei M; Tiwari A; Arnold LL; Lu X; Le XC; Cohen SM
Toxicology; 2008 Jul; 249(1):69-74. PubMed ID: 18502017
[TBL] [Abstract][Full Text] [Related]
17. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
[TBL] [Abstract][Full Text] [Related]
18. Using mathematical modeling to infer the valence state of arsenicals in tissues: A PBPK model for dimethylarsinic acid (DMA
Bilinsky LM; Thomas DJ; Fisher JW
J Theor Biol; 2019 Jan; 461():215-229. PubMed ID: 30393109
[TBL] [Abstract][Full Text] [Related]
19. Understanding arsenic carcinogenicity by the use of animal models.
Wanibuchi H; Salim EI; Kinoshita A; Shen J; Wei M; Morimura K; Yoshida K; Kuroda K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2004 Aug; 198(3):366-76. PubMed ID: 15276416
[TBL] [Abstract][Full Text] [Related]
20. Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat.
Cohen SM; Arnold LL; Uzvolgyi E; Cano M; St John M; Yamamoto S; Lu X; Le XC
Chem Res Toxicol; 2002 Sep; 15(9):1150-7. PubMed ID: 12230408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
